Monitoring of the medicines Adalimumab, infliximab and rituximab; tests for concentration and antibodies in serum to Helse Bergen HF
Buyer: SYKEHUSINNKJØP HF
- Published
- 2 February 2024
- Estimated value
- 6,750,000 kr
- Place of performance
- NO0A2
- Procedure
- open
- Lots
- 1
- Notice number
- 00070866-2024
- Reference
- 04783514-6b22-410e-8ef6-2ca08ecf15eb
- Official source
- Official source
CPV codes
- 33696500Reactivos de laboratorio
- 33690000Medicamentos diversos
Description
Framework agreement for tests for measuring concentration and antibodies directed at the medicines Adalimumab, Infliximab and Rituximab in human serum.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| MONTEBELLO DIAGNOSTICS AS | — | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 6,750,000 kr.
- Who is the buyer of this tender?
- The contracting authority is SYKEHUSINNKJØP HF (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.